Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aurobindo Pharma Ltd Recommends Final Dividend


Thursday, 30 May 2013 11:30am EDT 

Aurobindo Pharma Ltd announced that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has considered the final dividend at 50% (INR0.50 per equity share of INR1 each) on the equity share capital of the Company for the year 2012-13 has been recommended, subject to approval of members. The Company in the month of February 2013 has paid an interim dividend of 100% (INR1.00 per equity share of INR1 each) on the equity share capital of the Company for the year 2012-13. 

Company Quote

1205.1
70.35 +6.20%
27 Mar 2015